Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-11-18A Randomised,Double Blind, Placebo Controlled, Multicentre Trial of Abagovomab Maintenance Therapy in Patients With Epithelial Ovarian Cancer After Complete Response to First Line Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-11-10Study of the mTOR Inhibitor Temsirolimus(CCI-779) in Patients With CA125 Only Relapse of Ovarian Cancer. A Phase II Study by the Hellenic Cooperative Oncology Group.
-
CLINICAL_TRIALS study record update · 2011-11-08Evaluation of a Multiple Biomarker Assay to Estimate the Risk of Ovarian Cancer in Patients Presenting With a Pelvic Mass.
-
CLINICAL_TRIALS study record update · 2011-11-07Epidemiology of Ovarian Cancer in Taiwan
-
CLINICAL_TRIALS study record update · 2011-11-03A Phase III, Multicenter, Randomized, Blinded, Placebo-controlled Trial of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Platinum-sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-10-12A Phase II, Non-Randomized Study of Abraxane Plus Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2011-09-30A RENEW Intervention for Elderly Cancer Survivors
-
CLINICAL_TRIALS study record update · 2011-09-26Phase II Study of Paclitaxel With Imatinib Mesylate (Gleevec) in Taxane-pretreated Ovarian and Other Cancers of Mullerian Origin
-
CLINICAL_TRIALS study record update · 2011-09-20A Phase II, Double-blind, Placebo-controlled, Multi-centre, Randomised Study of AZD0530 in Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-09-07Clinical Benefit of Topoisomerase Downregulation: A Phase I Pilot Study
-
CLINICAL_TRIALS study record update · 2011-07-22Weekly Administration of Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2011-07-19Molecular Detection of Circulating Cancer Cells in Breast, Ovarian, Colon and Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2011-07-15Randomized Double-Blind Controlled Phase III Trial of Hyperbaric Oxygen Therapy in Patients Suffering Long-Term Adverse Effects of Radiotherapy for Pelvic Cancer (HOT II)
-
CLINICAL_TRIALS study record update · 2011-07-13HSCT-CHESS to Enhance Hematopoietic Transplant Recovery
-
CLINICAL_TRIALS study record update · 2011-07-08Phase I Study of Capecitabine (Xeloda) and Radiation Therapy in Patients With Locally Advanced Cervical and Pelvic Malignancies
-
CLINICAL_TRIALS study record update · 2011-06-29The Impact of Bisphosphonates on Bone Loss in Patients Undergoing Surgery and Postoperative Chemotherapy for Gynecologic Malignancies.
-
CLINICAL_TRIALS study record update · 2011-06-22Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 in Advanced Ovarian Cancer Using Autologous Peripheral Blood Stem Cell Rescue (PBSCR) to Control Myelotoxicity
-
CLINICAL_TRIALS study record update · 2011-06-16A Phase 1 and 2 Clinical Trial of ALIMTA® (Pemetrexed) in Combination With Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2011-06-07Characterization of Ovarian Cancer Stem Cell: Focus on Identification of Biomarker and Drug Resistance
-
CLINICAL_TRIALS study record update · 2011-06-03Retrospective Study to Develop a Training Set for a Cross Validated Chemoresponse Marker Algorithm in Cases With Ovarian, Peritoneal or Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2011-05-23Dose Dense Administration of Paclitaxel and Carboplatin Combination as 1st Line Treatment in Patients With Ovarian Carcinoma
-
CLINICAL_TRIALS study record update · 2011-05-18A Placebo-Controlled Study on the Effect of Epoetin Alfa in Patients With Malignancy Receiving Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-05-11Korean Hereditary Breast Cancer Study
-
CLINICAL_TRIALS study record update · 2011-05-10Phase I Study of Paclitaxel (Taxol) and Bortezomib (Velcade) in Patients With Refractory Solid Tumor Malignancies Involving an Activated MAPK Pathway
-
CLINICAL_TRIALS study record update · 2011-04-26Phase I Trial of Bortezomib (NSC 681239, IND#58443) and Carboplatin in Recurrent or Progressive Epithelial Ovarian Cancer or Primary Peritoneal Cancer